Twitter | Search | |
Search Refresh
BioPortfolio - Eli Lilly - news and research Oct 17
Human medicines European public assessment report EPAR Duloxetine Lilly duloxetine NeuralgiaDiabetic NeuropathiesDepressive Disorder Major Date of authorisation 08122014 Revision 6 Status Authorised: Human medicines European public assessment…
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 15
Checkmate Pharmaceuticals Announces Additions to Management Team: Experienced Industry Executives to Lead Clinical Research and Regulatory Affairs with the Appointments of James Wooldridge MD as Chief Medical Officer and Steven Hamburger PhD as…
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 11
Lilly's 1drug migraine business gets support with new approval: An OK for Reyvow an acute migraine drug complements Lilly&39;s preventive therapy Emgality and could strengthen the company&39;s footing in an increasingly crowded market.
Reply Retweet Like
Paris Welch Romero Oct 16
FDA approved new migraine "rescue" med. An antagonist targeted at serotonin receptor. Takes 2 hours to be effective. First in new classification of medicine: Ditan.
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 15
Lilly shuttering UK neuroscience research site: Most employees will be relocated to a new facility in the area although Lilly expects to lay off as many as 80 workers.
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 15
Real Time Coverage BIOConvention BIO2019 Dealmakers Intentions 2019 Market Outlook June 5 Philadelphia PA: Real Time Coverage BIOConvention BIO2019 Dealmakers&8217; Intentions 2019 Market Outlook June 5 Philadelphia PA Reporter Stephen J…
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 15
FDA Approves FirstofitsKind Acute Migraine Treatment: The U.S. Food and Drug Administration approved Eli Lilly's Reyvow lasmiditan for the acute treatment of migraines.
Reply Retweet Like
Shelli Kenlein Papke Oct 15
Months after winning approval for Emgality as a treatment for episodic cluster headache, Eli Lilly scored another victory in the migraine area.
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 18
EU committee recommends clearance of Eli Lilly's nasally administered glucagon for severe hypoglycaemia httpswww.firstwordpharma.comnode1674837Â : EU committee recommends clearance of Eli Lilly's nasally administered glucagon for severe…
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 11
Remembering Harrison Cook Vice President for International Government Affairs at Eli Lilly and Company: Guest authors of this blog are
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 15
Eli Lilly to close neuroscience research centre in the UK httpswww.firstwordpharma.comnode1673971Â : Eli Lilly to close neuroscience research centre in the UK httpswww.firstwordpharma.comnode1673971
Reply Retweet Like
BioPortfolio - Eli Lilly - news and research Oct 11
Eli Lilly's Reyvow approved by FDA for acute treatment of migraine in adults httpbit.ly2MyuyXXÂ FDA pharma: Eli Lilly's Reyvow approved by FDA for acute treatment of migraine in adults httpbit.ly2MyuyXX FDA pharma
Reply Retweet Like
Neil Sankar M.D.,MPH Oct 16
Eli Lilly drug for pancreatic Malignancy Fails .
Reply Retweet Like
PharmaState Oct 14
Reply Retweet Like
BiopharmaAsia Oct 15
Positive Results for ® (ixekizumab) Presented by Lilly at the 28th Annual European Academy of Dermatology and Venereology (EADV) Congress -
Reply Retweet Like
Hottest Stocks Now Oct 12
FDA OKs 's REYVOW for the acute treatment of migraine, with or without aura, in adults
Reply Retweet Like
Hottest Stocks Now Oct 16
Reveals findings from late-stage study evaluating pegilodecakin + FOLFOX Vs FOLFOX alone in patients with metastatic pancreatic cancer
Reply Retweet Like
Invstr Oct 14
Today We are Watching 👀 Today we are watching 's and . Don't miss out!
Reply Retweet Like
Plexus Ventures Oct 17
Reply Retweet Like
janszky 23h
Auf zu Nr. 5 in dieser Woche. Tausche gegen . Tausche Chefärzte gegen Runde. Danke für Euren Zukunftsgeist. Hallo freue mich auf beyond & .
Reply Retweet Like